Abbott Laboratories vs. Connect Biopharma Holdings Limited Ordinary Shares
ABT
Abbott Laboratories
$102.83 +0.58%
VS CNTBConnect Biopharma Holdings Limited Ordinary Shares
$2.04 -0.97%
Abbott Laboratories (ABT) comes out ahead, leading on 8 of 8 compared factors.
Size & Scale
| ABT | CNTB | |
|---|---|---|
| Market Cap | $176.90 billion | $129.73 million |
| Revenue (TTM) | $46.59 billion | $2.95 million |
| Net Income (TTM) | $5.42 billion | $-68,991,000 |
ABT leads on 3 of 3 size & scale factors.
Valuation
| ABT | CNTB | |
|---|---|---|
| P/E Ratio | 33.28 | — |
| Price / Book | 3.42 | 4.83 |
| Price / Sales | 3.80 | 43.93 |
ABT leads on 2 of 2 valuation factors.
Profitability
| ABT | CNTB | |
|---|---|---|
| Net Margin | 11.65% | -2336.30% |
| Return on Equity | 10.48% | -256.84% |
ABT leads on 2 of 2 profitability factors.
Dividend
| ABT | CNTB | |
|---|---|---|
| Dividend Yield | 2.45% | — |
| Payout Ratio | 81.55 | — |
ABT and CNTB split the dividend factors evenly.
Risk & Sentiment
| ABT | CNTB | |
|---|---|---|
| Short Interest | 0.57% | 1.23% |
ABT leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABT overview, ABT financials, CNTB overview, CNTB financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.